Search research articles
Contact Us
Filters
Showing results (1-10 of 64) with videos related to
Page
of 7
Sort By:
Oncoimmunology
|
August 13, 2014
Linking tumor hypoxia with VEGFR2 signaling and compensatory angiogenesis: Glycans make the difference
Diego O Croci, Gabriel A Rabinovich
Immunity
|
March 27, 2012
Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer
Gabriel A Rabinovich, Diego O Croci
Current Opinion in Hematology
|
May 23, 2013
Galectins in hematological malignancies
Mirta Giordano, Diego O Croci, Gabriel A Rabinovich
Histology and Histopathology
|
December 15, 2010
Regulated expression of galectin-3, a multifunctional glycan-binding protein, in haematopoietic and non-haematopoietic tissues
Victoria Sundblad, Diego O Croci, Gabriel A Rabinovich
Nature Reviews. Urology
|
February 2, 2022
Galectins as potential therapeutic targets in STIs in the female genital tract
Agustin L Lujan, Diego O Croci, Gabriel A Rabinovich, et al.
Frontiers in Bioscience (Scholar Edition)
|
December 29, 2011
Integrating structure and function of 'tandem-repeat' galectins
Maria F Troncoso, Maria T Elola, Diego O Croci, et al.
Nature Reviews. Drug Discovery
|
February 9, 2023
Targeting galectin-driven regulatory circuits in cancer and fibrosis
Karina V Mariño, Alejandro J Cagnoni, Diego O Croci, et al.
Current Pharmaceutical Design
|
January 30, 2010
Overcoming the hurdles of tumor immunity by targeting regulatory pathways in innate and adaptive immune cells
Norberto W Zwirner, Diego O Croci, Carolina I Domaica, et al.
Handbook of Experimental Pharmacology
|
April 14, 2017
Immune-Mediated and Hypoxia-Regulated Programs: Accomplices in Resistance to Anti-angiogenic Therapies
Diego O Croci, Santiago P Mendez-Huergo, Juan P Cerliani, et al.
Journal of Circadian Rhythms
|
April 21, 2010
"Time sweet time": circadian characterization of galectin-1 null mice
Leandro P Casiraghi, Diego O Croci, Francoise Poirier, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 64) with videos related to
Sort By:
Page
of 7
Oncoimmunology
|
August 13, 2014
Linking tumor hypoxia with VEGFR2 signaling and compensatory angiogenesis: Glycans make the difference
Diego O Croci, Gabriel A Rabinovich
Immunity
|
March 27, 2012
Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer
Gabriel A Rabinovich, Diego O Croci
Current Opinion in Hematology
|
May 23, 2013
Galectins in hematological malignancies
Mirta Giordano, Diego O Croci, Gabriel A Rabinovich
Histology and Histopathology
|
December 15, 2010
Regulated expression of galectin-3, a multifunctional glycan-binding protein, in haematopoietic and non-haematopoietic tissues
Victoria Sundblad, Diego O Croci, Gabriel A Rabinovich
Nature Reviews. Urology
|
February 2, 2022
Galectins as potential therapeutic targets in STIs in the female genital tract
Agustin L Lujan, Diego O Croci, Gabriel A Rabinovich, et al.
Frontiers in Bioscience (Scholar Edition)
|
December 29, 2011
Integrating structure and function of 'tandem-repeat' galectins
Maria F Troncoso, Maria T Elola, Diego O Croci, et al.
Nature Reviews. Drug Discovery
|
February 9, 2023
Targeting galectin-driven regulatory circuits in cancer and fibrosis
Karina V Mariño, Alejandro J Cagnoni, Diego O Croci, et al.
Current Pharmaceutical Design
|
January 30, 2010
Overcoming the hurdles of tumor immunity by targeting regulatory pathways in innate and adaptive immune cells
Norberto W Zwirner, Diego O Croci, Carolina I Domaica, et al.
Handbook of Experimental Pharmacology
|
April 14, 2017
Immune-Mediated and Hypoxia-Regulated Programs: Accomplices in Resistance to Anti-angiogenic Therapies
Diego O Croci, Santiago P Mendez-Huergo, Juan P Cerliani, et al.
Journal of Circadian Rhythms
|
April 21, 2010
"Time sweet time": circadian characterization of galectin-1 null mice
Leandro P Casiraghi, Diego O Croci, Francoise Poirier, et al.
Page
of 7